Sign In
Buy UBS
$47.67
+0.350 (+0.740%)
At Close: Jun 04, 2026
Five UBS Financial Advisors in the Pacific Desert Market Recognized by Forbes as Top Next-Gen Advisors
04:41pm, Wednesday, 09'th Oct 2024
SAN DIEGO & NEWPORT BEACH, Calif. & PHOENIX & TUCSON, Ariz. & HONOLULU--(BUSINESS WIRE)-- #AaronRottenstein--Five UBS financial advisors based in Pacific Desert Market named to Forbes Top Next-Gen Wea
UBS Declares Coupon Payments on 14 ETRACS Exchange Traded Notes
04:30pm, Monday, 07'th Oct 2024
NEW YORK--(BUSINESS WIRE)--UBS Investment Bank today announced coupon payments for 11 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Not
Higher for longer will be tougher on banks, says UBS' Erika Najarian
11:58am, Monday, 07'th Oct 2024
Erika Najarian, UBS large cap banks analyst, joins 'Squawk on the Street' to discuss what bank investors want from interest rates, if the bank outlooks stand, and much more.
UBS Hires $400 Million Financial Advisor Team in Manchester, NH
10:09am, Friday, 04'th Oct 2024
MANCHESTER, N.H.--(BUSINESS WIRE)--UBS Wealth Management USA today announced that Financial Advisor Jared Berault has joined the firm in Manchester, New Hampshire. Jared is responsible for managing mo
OpenAI establishes $4 bln credit facility
10:25am, Thursday, 03'rd Oct 2024
OpenAI said on Thursday it has established a new $4 billion credit facility with JPMorgan Chase, Citi, Goldman Sachs, Morgan Stanley, Santander, Wells Fargo, SMBC, UBS, and HSBC, in addition to the $6
Middle East escalation may cause ‘knee-jerk reactions' but gold and silver rallies will be driven by macro and rates – UBS' Teves
04:13pm, Tuesday, 01'st Oct 2024
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Ceres Power gets UBS backing as ‘de-risked' green hydrogen firm
04:41am, Tuesday, 01'st Oct 2024
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) has been highlighted as a “de-risked” player in the green hydrogen market after announcing a cost-cutting plan in half-year results last month. UBS an
UBS Mulls JV With India's 360 One WAM to Expand Wealth Management
11:35am, Monday, 30'th Sep 2024
UBS Group seeks to form a JV with India's 360 One WAM to expand its services to high-net-worth individuals and capitalize on the rapidly growing market.
UBS chair warns against big increase in capital requirements, newspaper reports
06:41pm, Saturday, 28'th Sep 2024
UBS Chair Colm Kelleher warned on Sunday that the Swiss government's plans to strengthen capital requirements for big banks could damage the country's position as a financial centre.
Participation notification by UBS Group AG
02:30am, Friday, 27'th Sep 2024
Brussels, September 27, 2024, 08:30 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency not
Xtract One Technologies Teams Up with UBS Arena, Home of the NHL's New York Islanders
07:00am, Thursday, 26'th Sep 2024
TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and securi
Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
05:00pm, Wednesday, 25'th Sep 2024
IRVINE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize tr
Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024
07:30am, Wednesday, 25'th Sep 2024
BEDFORD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
07:00am, Wednesday, 25'th Sep 2024
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on Wedn
‘No recovery in sight' for LVMH, warn analysts
03:31am, Wednesday, 25'th Sep 2024
Investment analysts at UBS have warned that weakening sales growth at LVMH is posing a risk to margins and causing a delay to a potential recovery phase for the global luxury bellwether. UBS analyst Z
